Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
restructuring
Biotech
Novartis trims ‘select number’ of biomedical research roles
After several staff consolidation moves in recent weeks, Novartis is again trimming its ranks, albeit in what appears to be a more limited move.
Fraiser Kansteiner
May 15, 2026 10:58am
Fierce Biotech Layoff Tracker 2026: Novartis, Takeda & more
May 15, 2026 8:00am
Charles River's incoming CEO talks R&D processes, reorg goals
Jan 28, 2026 12:58pm
Fierce Biotech Layoff Tracker 2025: Voyager, Intercept & more
Dec 17, 2025 1:00pm
Prelude loses CMO, pauses SMARCA2 degraders, scores Incyte cash
Nov 4, 2025 9:40am
Galapagos to wind down cell therapy unit, threatening 365 jobs
Oct 21, 2025 9:30am
